By: Office of Communications and Information Prov. Java
Monday, January 18, 2010
University of Airlangga (Airlangga University) Surabaya find a cure for bird flu virus (H5N1) and swine flu (H1N1). Vaccines of the two viruses were produced in the country, namely in the Laboratory of Bio-Safety Level 3 Avian Influenza Research Center (BSL3 AIRC)
Chairman of the AIRC Laboratory, Dr. CA Nidhom drh MS, confirmed on Monday (18 / 1), said the vaccine is now being continuously be mass produced. Maybe not all people know that the laboratory is the first in Southeast Asia. (Dra)
-snip-
With a fund of Rp 120 billion, stood at the AIRC an area of 230 square meters. Location lies between the Tropical Disease Center and Faculty of Veterinary Medicine at the University of Airlangga Kampus C (Airlangga University), Surabaya. "Until now we still continue to monitor vaccines are being produced in this laboratory, made the seed (seed) vaccine for the H5N1 and H1N1" said Nidhom
He explained, the launch of this vaccine seeds have been made Vice President Boediono at Airlangga Kampus C Rectorate Muyorejo, around November 2009 and then. We have the seed already sent to PT Bio Farma is served mass produce it. Nidhom said, it is now is still monitoring (monitoring) to maintain the possibility of change.
"But until now we have made seed still be able to cover these viruses. As the most upstream, this lab is always ready to update the seed if there is a change in swine influenza virus or bird flu, "said faculty member Faculty of Veterinary Medicine (FKH) Unair.
Nidhom explained, making H1N1 vaccine was first performed. Therefore, for the H5N1 vaccine, it could have to wait for delivery of the virus from the Ministry of Health RI.
In addition, currently the second seed was completed. The establishment of this laboratory became one of the evidence concern in dealing with Indonesia bird flu. Owned equipment is not kidding. All the equipment was imported directly from Japan and made of stainless steel. Even the installation of equipment made by the technicians from Japan. "Tools are not our own pair because the system is very complicated and complex. So should be done by experts, "said Nidhom.
According to him, researchers are not allowed in the lab for a full day. They were given a maximum of three hours to conduct research in the laboratory. Therefore, the whole room was given a negative air pressure. This pressure serves to keep the virus in the virus in the laboratory so as not to spread out. If you are in the negative-pressure room for more than three hours, researchers may feel sleepy even fainted from lack of oxygen.
"Lab space is really dirty. His name research, could have been an accident and spilled the virus. To keep the virus was still at home and not spread out, we provide a negative air pressure, "he said.
Negative pressure provided vary, depending on the type of room. To the locker room, the pressure was only minus 20 degrees in atmospheric pressure (PSI). The corridor was raised to minus 30 degrees PSI.
Meanwhile, the biggest pressure in the laboratory animals, human viruses, and laboratory animal viruses, ie, minus 40 degrees PSI. "Cage and the virus lab greatest pressure because the place is the dirtiest air," he said.
In addition, the air is made to flow to where the pressure is lowest. From the locker room, the air flows into the hallway before they spread to each room.
In this room, the air and then filtered before it is released to the atmosphere. "So the lab is completely not harm the environment because anything that comes out of here already past the screening process to clean," continued Nidhom.
In addition, researchers also should not be carelessly carrying goods out of the lab because it was feared the virus. As a precaution, the data obtained is sent through a computer network or fax.
This is an attempt to anticipate Avoid getting a virus that came out of the laboratory.
For the purposes of this vaccine manufacturing project disburse government funds around Rp1, 3 trillion. This has been revealed Endang Rahayu Minister of Health inaugurated the launch of Setyaningsih as vaccine seed some time ago. The funds are allocated for a period of four years. Each year will produce about 20 million doses, or one-tenth of the population is Indonesia.
No comments:
Post a Comment